Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cooper Hill Partners is a specialized investment firm focused exclusively on the healthcare and life sciences sectors. Based in New York City, the firm manages capital dedicated to investing in both public and private companies across the biotechnology, pharmaceutical, and medical technology landscapes. Cooper Hill Partners employs a research-intensive approach, utilizing deep clinical and fundamental analysis to identify high-growth opportunities in innovative medical therapies and healthcare services. Founded by Gregory Suchanyc, the firm has been a long-standing participant in the healthcare investment ecosystem, providing strategic capital to emerging and established entities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cooper Hill Partners.